Animal models for antiviral chemotherapy

Area of Science:

• Pharmacology
• Virology
• Preclinical Research

Background:

• Animal models have historically been indispensable for preclinical antiviral therapy evaluation.
• They facilitate the study of complex in vivo virus-drug interactions and pathogenesis.

Purpose of the Study:

• To review the utility and challenges of animal models in antiviral drug development.
• To highlight the importance of critical evaluation for interpreting animal data in human antiviral therapy predictions.

Main Methods:

• Review of existing and potential animal models for antiviral drug screening.
• Discussion of advancements, including transgenic animal models for novel virus studies.

Main Results:

• Animal models have successfully addressed key questions in antiviral chemotherapy.
• New technologies like transgenic models expand the scope of in vivo antiviral research.

Conclusions:

• Animal models will remain vital for antiviral drug evaluation for the foreseeable future.
• Critical assessment of animal model limitations is necessary to ensure the reliability of preclinical data for human therapies.